Wells Fargo’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$299K Buy
51,752
+15,386
+42% +$88.8K ﹤0.01% 4126
2025
Q1
$240K Buy
36,366
+1,377
+4% +$9.09K ﹤0.01% 4140
2024
Q4
$305K Buy
34,989
+11,427
+48% +$99.5K ﹤0.01% 4037
2024
Q3
$460K Sell
23,562
-881
-4% -$17.2K ﹤0.01% 3676
2024
Q2
$503K Sell
24,443
-1,804
-7% -$37.1K ﹤0.01% 3578
2024
Q1
$560K Buy
26,247
+2,656
+11% +$56.7K ﹤0.01% 3480
2023
Q4
$339K Sell
23,591
-36,252
-61% -$521K ﹤0.01% 3766
2023
Q3
$546K Buy
59,843
+1,386
+2% +$12.6K ﹤0.01% 3443
2023
Q2
$618K Sell
58,457
-15,174
-21% -$161K ﹤0.01% 3584
2023
Q1
$901K Buy
73,631
+56,555
+331% +$692K ﹤0.01% 3230
2022
Q4
$212K Sell
17,076
-3,749
-18% -$46.5K ﹤0.01% 3885
2022
Q3
$284K Sell
20,825
-1,073
-5% -$14.6K ﹤0.01% 3787
2022
Q2
$402K Sell
21,898
-6,572
-23% -$121K ﹤0.01% 3645
2022
Q1
$458K Sell
28,470
-19,133
-40% -$308K ﹤0.01% 4194
2021
Q4
$667K Buy
47,603
+9,030
+23% +$127K ﹤0.01% 4155
2021
Q3
$722K Sell
38,573
-3,253
-8% -$60.9K ﹤0.01% 4202
2021
Q2
$873K Sell
41,826
-64,367
-61% -$1.34M ﹤0.01% 4056
2021
Q1
$3M Sell
106,193
-64,779
-38% -$1.83M ﹤0.01% 3153
2020
Q4
$5.58M Buy
170,972
+118,836
+228% +$3.88M ﹤0.01% 2621
2020
Q3
$1.6M Sell
52,136
-477
-0.9% -$14.6K ﹤0.01% 3437
2020
Q2
$858K Buy
52,613
+13,008
+33% +$212K ﹤0.01% 3827
2020
Q1
$394K Sell
39,605
-13,762
-26% -$137K ﹤0.01% 4086
2019
Q4
$733K Buy
53,367
+11,383
+27% +$156K ﹤0.01% 3999
2019
Q3
$637K Sell
41,984
-464
-1% -$7.04K ﹤0.01% 4104
2019
Q2
$835K Buy
42,448
+1,346
+3% +$26.5K ﹤0.01% 3926
2019
Q1
$682K Buy
41,102
+6,581
+19% +$109K ﹤0.01% 4109
2018
Q4
$485K Sell
34,521
-7,701
-18% -$108K ﹤0.01% 4230
2018
Q3
$739K Buy
42,222
+13,489
+47% +$236K ﹤0.01% 4089
2018
Q2
$523K Sell
28,733
-30,715
-52% -$559K ﹤0.01% 4318
2018
Q1
$1.12M Buy
59,448
+24,343
+69% +$457K ﹤0.01% 3774
2017
Q4
$537K Buy
35,105
+28,777
+455% +$440K ﹤0.01% 4243
2017
Q3
$94K Buy
+6,328
New +$94K ﹤0.01% 5028